Earnings release
Page 1
PRESS RELEASE | Guerbet • Revenue at 30 September 2026 Business in line with Group expectations Revenue at 30 September 2026 of € 573.8m , down 1.3 % at CER¹ and like - for- like² ; excluding China , business grew by 1 % , with a positive contribution from the three regions ( EMEA , Americas and Asia ) • In the third quarter , revenue fell by 3.6 % at CER and like - for - like , and was stable excluding China All financial targets confirmed for 2026 Villepinte , 22 October 2026 , 5.45 p.m .: Guerbet ( FR0000032526 GBT ) , a global specialist in contrast agents and solutions for medical imaging , is publishing its revenue for the first nine months of 2026 . At 30 September 2026 , Group revenue totalled € 573.8 million , down 2.2 % on a reported basis compared with the first nine months of 2025. At constant exchange rates ( CER ) 1 , the decline was 1.3 % over the period , with the negative exchange rate effect of € 4.8 million confined to the first six months of the year and largely linked to the depreciation of the Japanese yen . As there was a very small scope effect , the change at CER and like - for - like² was also -1.3 % . Excluding China , where the healthcare product market is undergoing a major restructuring , Guerbet's revenue would have grown over the period ( + 1 % ) . In the third quarter alone , revenue at CER and like - for - like was down 3.6 % , but was stable excluding China . 1 Constant exchange rates : the exchange rate impact was eliminated by recalculating sales for the period on the basis of the exchange rates used for the previous financial year . 2 Excluding sales in 2026 of components and finished products related to the urology business ( sold in July 2024 ) and sales in 2025 of microcatheters . Contacts : Guerbet Jérôme Estampes , Chief Financial Officer +33 ( 0 ) 1 45915000 / jerome.estampes@guerbet.com Christine Allard , SVP Public Affairs and Corporate Communications +33 6 30115782 / christine.allard@guerbet.com Seitosei.Actifin Marianne Py , Financial Communication +33 6 85527693/marianne.py@seitosei-actifin.com Jennifer Jullia , Press +33 6 02084549/jennifer.jullia@seitosei-actifin.com O in www.guerbet.com 1